ABOUT PHARMA EXCIPIENTS

“The current condition has exposed some structural weaknesses during the EU’s medicines offer chain as well as a significant dependence on non-EU countries for active pharmaceutical ingredients,” Kyriakides said. She recommended that provide chain challenges be dealt with within an EU pharmaceutical strategy anticipated to be released by the